Prowormer flavoured tablets for medium & small dogs
Country: Ireland
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
06-08-2012
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
febantel 150 mg, praziquantel 50 mg, pyrantel 50 mg
Available from:
CEVA Animal Health
ATC code:
QP52AA51
Pharmaceutical form:
Tablet
Therapeutic group:
praziquantel, combinations
Therapeutic area:
Dogs
Authorization date:
2011-11-23
Summary of Product characteristics
Revised: December 2011
AN: 00111/2011
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
PROWORMER Flavoured tablets for medium and small dogs [UK, IE]
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains:
ACTIVE SUBSTANCES:
Febantel ............................................................................................. 150 mg
Pyrantel (as embonate) ...................................................................... 50 mg
Praziquantel ........................................................................................ 50 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Yellow brown, oval tablet with a score line on both sides.
The tablets can be divided into equal halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs (adults and puppies).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed infections by adult cestodes and nematodes of the following
species:
Nematodes:
Ascarids:
_Toxocara canis_, _Toxascaris leonina_ (adult and late immature forms).
Hookworms: _Uncinaria stenocephala_, _Ancylostoma caninum_ (adults).
Whipworms: _Trichuris vulpis_ (adults).
Cestodes:
Tapeworms: _Echinococcus spp., Taenia _spp., _Dipylidium caninum_ (adult and
immature forms).
4.3
CONTRAINDICATIONS
Revised: December 2011
AN: 00111/2011
Page 2 of 7
Do not use in animals with a known sensitivity to the active ingredients or to any of the
excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As a precautionary measure to prevent the establishment of _Echinococcus _
_multilocularis_, it is recommended that all
Read the complete document
